Apotekforeningen
FLIActiveOrg 971033541Slemdalsveien 1, 0369 OsloActivities of business and employers membership organisations· NACE 9411Est. 1881 · 145 years old14 employeeshttps://apotek.no
Loading company…
Overview
Apotekforeningen is a Norwegian FLI based in Oslo, operating in the Activities of business and employers membership organisations sector. Incorporated in 1881, the company has 14 employees and reported revenue of NOK 25.4m in its latest annual filing.
Revenue 2025
0B NOK
+4% vs 2024
EBITDA margin
−295.0 %
+2% vs 2024
Net profit 2025
0.1B NOK
-1% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
97.8 %
StrongAmong the 30% highest rated companies in the industry
20212025
Liquidity ratioCurrent assets ÷ Short-term debt
125.6×
Very strongAmong the 10% highest rated companies in the industry
20212025
Return on assets (ROA)Net profit ÷ Total assets × 100
9.3 %
StrongAmong the 40% highest rated companies in the industry
20212025
EBITDA — year on year
NOK millionsKey figures
Annual report 2025| Revenue | 0B NOK | +4% |
| EBITDA | -0.1B NOK | +2% |
| Net profit | 0.1B NOK | -1% |
| Total assets | 1.5B NOK | +10% |
| Equity | 1.5B NOK | +11% |
| Employees | 14 | — |
Company information
Legal name
APOTEKFORENINGEN
Org number
971033541
Legal form
Forening/Lag/Innretning
NACE code
Founded
16 May 1881 · 145 years
Share capital
—
Employees
14 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Not yet available for this organisation form.
Contact
Address
Slemdalsveien 1, 0369 Oslo
Website
https://apotek.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), Apotekforeningen reported revenue of NOK 25.4m, an increase of 4% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of NOK 142.2m, and the EBITDA margin stood at -295%.
At the end of 2025, equity financed 97.8% of the balance sheet, and current assets covered short-term debt 125.6 times.
Financials
Revenue
NOK millionsEBITDA
NOK millionsIncome statement
NOK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 25,369 | 24,282 | 23,133 | 22,205 | 21,060 |
| Staff expenses | -27,704 | -27,737 | -26,243 | -25,468 | -25,733 |
| EBITDA | -74,830 | -76,434 | -77,347 | -72,639 | -41,186 |
| Depreciation & amort. | -789 | -18 | -18 | -9 | -0 |
| EBIT | -75,618 | -76,452 | -77,365 | -72,647 | -41,186 |
| Net financials | 217,853 | 220,586 | 147,187 | 9,383 | 1,079,473 |
| Profit before tax | 142,235 | 144,134 | 69,822 | -63,264 | 1,038,287 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | 142,235 | 144,134 | 69,822 | -63,264 | 1,038,287 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
NOK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 1,530,481 | 1,387,864 | 1,240,530 | 1,160,880 | 1,250,135 |
| Equity | 1,496,586 | 1,354,352 | 1,210,218 | 1,140,396 | 1,203,660 |
| Long-term debt | 0 | 0 | -19,864 | -13,406 | -12,157 |
| Short-term debt | 9,324 | 10,610 | 10,448 | 7,078 | 34,318 |
| Total debt | 9,324 | 10,610 | 10,448 | 7,078 | 34,318 |
Financial ratios
5-year trendEBITDA margin
-295.0 %
20212025
Equity ratio
97.8 %
StrongAmong the 30% highest rated companies in the industry
20212025
Return on equity
9.5 %
AverageAround the average of companies in the same industry
20212025
Net profit margin
560.7 %
Very strongAmong the 10% highest rated companies in the industry
20212025
Asset turnover
0.02×
WeakAmong the 30% lowest rated companies in the industry
20212025
Debt / equity
0.02×
Very strongAmong the 10% highest rated companies in the industry
20212025
Sector performance
26 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Gross marginStrong
Among the 40% highest rated companies in the industry
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginVery weak
Among the 10% lowest rated companies in the industry
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginVery strong
Among the 10% highest rated companies in the industry
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Average
Around the average of companies in the same industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Strong
Among the 40% highest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Average
Around the average of companies in the same industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Weak
Among the 30% lowest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioWeak
Among the 30% lowest rated companies in the industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioVery strong
Among the 10% highest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioVery strong
Among the 10% highest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioVery strong
Among the 20% highest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityVery strong
Among the 20% highest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalAverage
Around the average of companies in the same industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioVery weak
Among the 10% lowest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioStrong
Among the 30% highest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioVery strong
Among the 10% highest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityVery strong
Among the 10% highest rated companies in the industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityStrong
Among the 30% highest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtVery strong
Among the 10% highest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtVery weak
Among the 10% lowest rated companies in the industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageVery weak
Among the 10% lowest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtStrong
Among the 30% highest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginStrong
Among the 40% highest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverWeak
Among the 30% lowest rated companies in the industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
One-year change in equityStrong
Among the 40% highest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtStrong
Among the 30% highest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Equity to contributed capitalNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
Annual reports & filings
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PT Chief Executive Officer | Chief Executive Officer | 2012 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
JI Board of Directors | Board of Directors | 2026 |
RS Board of Directors | Board of Directors | 2026 |
TP Board of Directors | Board of Directors | 2020 |
HR Board of Directors | Board of Directors | 2020 |
KV Chairman | Chairman | 2025 |
KM Board of Directors | Board of Directors | 2022 |
Former (5)
AP Board of Directors | Board of Directors | 2020 – 2023 |
RS Board of Directors | Board of Directors | 2020 – 2025 |
TK Board of Directors | Board of Directors | 2025 – 2026 |
ØA Deputy Chairman | Deputy Chairman | 2020 – 2026 |
LH Chairman | Chairman | 2020 – 2025 |
Shareholders
Active legal ownersNo shareholder data available.
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
Apotekforeningen (this company)
Apokus AS34% ownedDifa AS100% ownedAs Apotekernes Hus66.0061% ownedFarmalogg AS100% ownedServiceproduksjon As91.4286% ownedBoard network connections
Board members of Apotekforeningen also hold positions in 110 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Terje Kvaal | Board of Directors | 23 companiesMany roles |
| Håvard Røkke | Board of Directors | 18 companiesMany roles |
| Jaan Ivar Gjærum Semlitsch | Board of Directors | 14 companiesMany roles |
| Anders Per Erik Larsson | Board of Directors | 14 companiesMany roles |
| Øyvind Andreas Winther | Deputy Chairman | 9 companiesMany roles |
| Rune Spikseth | Board of Directors | 9 companiesMany roles |
| Per Torgeir Lund | Chief Executive Officer | 6 companiesMany roles |
| Kristin Veierød | Chairman | 6 companiesMany roles |
| Kathrine Mehlin Wessel | Board of Directors | 6 companiesMany roles |
| Ros-Marie Soo Yeun Grusén | Board of Directors | 4 companies |
| Tore Prestegard | Board of Directors | 1 company |
Frequently asked questions
What is the Org number of Apotekforeningen?
Apotekforeningen is registered with Brønnøysundsregistrene under Org 971033541.
What is the revenue of Apotekforeningen?
Apotekforeningen reported revenue of NOK 25.4m in 2025.
How many employees does Apotekforeningen have?
Apotekforeningen employs 14 people as of the latest annual report.
Who is the CEO of Apotekforeningen?
Per Torgeir Lund is the CEO of Apotekforeningen, in role since 2012.
Who is the chairman of Apotekforeningen?
Kristin Veierød chairs the board of Apotekforeningen, in role since 2025.
Where is Apotekforeningen headquartered?
Apotekforeningen's registered address is Slemdalsveien 1.